Supplementary Figure Legends
Fig. S2. Estimation of MV-associated LLO concentration. Purified recombinant
and crude vesicle extracts (10 μl equal to 5 μg, 1:2, 1:4, 1:8 and 1:16 dilutions) were analyzed by immunoblotting using polyclonal anti-LLO antiserum. Band density (arbitrary units) was correlated to LLO amount loaded per well (ng) with the help of the standard curve. Estimated concentration of LLO associated with vesicles is 23 μg/ml. hours in vitro and LLO was further analyzed by immunoblotting using polyclonal anti-LLO antibody; (B) MVs from both bacteria L. monocytogenes and V. cholerae were incubated together for 6 hours in vitro and VCC was further analyzed by immunoblotting using polyclonal anti-VCC antibody.
Fig. S6. Verification of cell death inhibitors.
The anti-necroptotic effect of Nec-1 and antiapoptotic effect of Z-VAD-FMK were verified by inducing necroptosis with shikonin (4 M) and apoptosis with TRAIL (160 ng/ml) in combination with cycloheximide (CHX, 20 ng/ml), respectively, for 4 hours, and further 1 h incubation with Nec-1 and Z-VAD-FMK. Images were acquired using live-cell imaging. Scale bar: 100 μm. 
